The Next AI Boom Takes Place in the Laboratory: Thermo Fisher and Sartorius Confirm New Demand
Reading Time: 4 minutes
At Thermo Fisher and Sartorius , one of the most exciting stories of the AI revolution is unfolding. While attention has so far focused mainly on chips and data centers, AI could now trigger a new investment cycle in laboratories. Because AI does not just make research more efficient. It allows scientists to generate significantly more drug candidates, molecules, and scientific hypotheses – all of which then need to be tested physically. This is where Thermo Fisher and Sartorius could benefit. Both companies are now confirming that AI-driven...
Read this article now with a free account.
Your benefits:
- Every month, you can read 5 articles from the premium section for free.
- Monthly 2 trial issues of the Trader newspaper for free.
- Create a personal watchlist with an overview of news about your stock.

